Conjupro Biotherapeutics Inc

We track 2 ClinicalTrials.gov studies led by Conjupro Biotherapeutics Inc. The portfolio skews toward Phase 1 (2 trials).

2 clinical trials sponsored by Conjupro Biotherapeutics Inc.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 2
100%

Trial Status Breakdown

Trials by Conjupro Biotherapeutics Inc

Phase I Dose Escalation and Cohort Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SYS6043 in Patients With Advanced/Metastatic Solid Tumors

NCT07424547 · RECRUITING · Phase 1

A Phase 1, Multicenter, Single Agent Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of CPO-100 in Adult Patients With Advanced Solid Tumors

NCT04931823 · TERMINATED · Phase 1

Frequently Asked Questions

How many clinical trials does Conjupro Biotherapeutics Inc sponsor?

Conjupro Biotherapeutics Inc currently sponsors 2 clinical trials tracked on ReadTheTrial. These span Phase 1.

What conditions does Conjupro Biotherapeutics Inc research?

Conjupro Biotherapeutics Inc conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Conjupro Biotherapeutics Inc recruiting for clinical trials?

Yes, Conjupro Biotherapeutics Inc currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More